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The Surgeon Speaks-Benny Weksler, MD, MBA

Dr. Benny Weksler, who is Board Certified in Surgery and Thoracic Surgery, is a leader in the innovative
technique of robotic surgery. “Like laparoscopic surgery, “Dr. Weksler explains, “robotic surgery is done via
only a few small incisions. However, instead of holding the surgical instruments, the surgeon sits at a
control panel and utilizes robotic arms to move the instruments.” He notes that robotic surgery is far safer
because it offers greater precision, smaller incisions, decreased blood loss, and less pain for the patient.
The only robotic system approved by the Food and Drug Administration is the da Vinci® Surgical System,
named after the famous artist who invented the first robot. “We are the only facility in Philadelphia using
robotic surgery for thoracic operations,” says Dr. Weksler. In 2008, Jefferson performed seven operations
utilizing this exciting new technology. That number will increase in 2009 and already includes four
robotassisted esophagectomies for patients like Florence Jackson.
Benny Weksler, MD, MBA Director, Minimally Invasive and Robotic Thoracic Surgery Program
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News in Brief

Those Who Give

Survivor Turned
Supporter
Diagnosed with and successfully
treated for breast cancer at Jefferson
in 1984, Marianne Connolly
returned when faced with a potential
diagnosis of pancreatic cancer in
2005. Feeling blessed by her
fortunate outcome and access to
excellent medical care, Marianne
and her husband Charles made a
very personal decision to support
Jefferson. They decided to contribute
to research efforts that would
translate into advanced treatment
for patients with pancreatic cancer.

“It is truly the generosity
and the example set forth
by the Connollys that
will provide us with the
resources necessary to fight
this complicated disease”
The Connollys have pledged
$100,000 to support Jefferson’s
cutting edge clinical and investigative
work in pancreatic cancer and its
related diseases. Charles J. Yeo, MD,
Samuel D. Gross Professor and Chair
of Surgery, leads a multidisciplinary
team of surgeons, radiologists, and
gastroenterologists in the new
Jefferson Pancreatic, Biliary, and
Related Cancers Center. The
Connolly gift helps Dr. Yeo and the
Center pursue research discoveries
and gain momentum in the ongoing
fight against these diseases.

David Tichansky, MD has joined the

Division of General Surgery as the
Director of the Bariatric and Metabolic
Surgery Program. He specializes in totally
laparoscopic bariatric surgery and is
assisted by Alise Kuhl, CRNP-BC. For a
schedule of free patient seminars, go to
www.jeffersonhospital.org/bariatric

David Tichansky, MD

Susan Lanza-Jacoby, PhD was awarded a R21 NIH grant to study

different types of calorie restriction on the progression of PanIN
lesions to Pancreatic Ductal Adenocarcinoma (PDA).
Marianne and Charles Connelly’s generous contribution to the Jefferson
Pancreatic, Biliary, and Related Cancers Center is making individualized
treatment strategies a realistic possibility for future patients.

“We feel very fortunate for the
incredible experience I had at
Jefferson, most recently under Dr.
Yeo’s care,” says Marianne. “It is a
great gift that we can use my
situation to assist others. By
supporting Dr. Yeo’s research, we
are able to turn a negative personal
situation into something that
provides hope to many people.”
“It is truly the generosity and the
example set forth by the Connollys
that will provide us with the resources
necessary to fight this complicated
disease,” says Assistant Professor
Jonathan Brody, PhD, who runs a
laboratory devoted to pancreatic
cancer in the Division of Surgical
Research. “With the Connolly’s
commitment to our pancreatic group
here at Jefferson, we will be able to
explore the realistic possibility of
providing individualized and
enhanced treatment strategies to
patients with pancreatic cancer. In
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short, without these resources, many
of the group’s good ideas would never
be tested or eventually put into
practice with patients.”
While the Connolly’s generous
pledge has made ambitious basic and
translational pancreatic cancer
research possible at Jefferson, several
other fronts still require funding.
One such project is the Jefferson
Pancreas Tumor Registry, a
longitudinal study which aims to arm
researchers with a better
understanding of the familial
components of pancreatic cancer and
to identify environmental and
occupational exposures that may
increase an individual’s risk of
developing the disease.
For more information, or to
make a gift to the Department of
Surgery, please contact Lara Allan
Goldstein at 215-955-8797 or
Lara.AllanGoldstein@jefferson.edu.
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Gerald A. Isenberg, MD and the Department of Surgery are co-

investigators in a NIH study of Wise-MD, a web based multimedia
teaching tool for surgical students created by New York University.
John Kairys, MD is a Co-Investigator on a Department of Defense

grant entitled, “3D Projection Environment for Molecular Design
and Surgical Simulation.” Eric Wickstrom, PhD, Professor of
Biochemistry and Molecular Biology, is the Principal Investigator.
Sharon Molotsky, RN, BSN, CCRC has been promoted to the newly

created position of Clinical Research Nurse Project Manager for the
Department of Surgery.
Paul J. DiMuzio, MD, PhD, was awarded first place for his

presentation, “Endothelial differentiation of adipose-derived
stem cells: How close have we really come?”, at the International
Federation for Adipose Therapeutics and Science (IFATS)
Conference, September 2009 in Toulouse, France.
May 31st marks the 25th anniversary of the first liver transplant
in the Delaware Valley performed at Jefferson. A celebratory
reception for liver transplant patients and families is planned for
Tuesday, May 5, 2009.
Save the Date: The Investiture of Cataldo Doria, MD, PhD
as the first Nicoletti Family Professor of Transplantation Surgery
will be held on June 17, 2009 at 4 p.m. in Connelly Auditorium,
Dorrance H. Hamilton Building. Please contact Lara Allan Goldstein
at 215-955-8797 if interested in attending.
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SurgicalSolutions
Minimally Invasive and Robotic General
Surgery an Option for More Patients

When Florence Jackson, 73, had some
difficulty swallowing her food one evening,
her husband insisted she see her doctor.
She mentioned it at her six-month checkup, and notes that years earlier she had
suffered from acid reflux, which is known
to be a possible cause of esophageal
cancer. A barium swallow test revealed an
obstruction in her esophagus.
In southern Delaware, where Florence
lives, there was no facility that could do an
endoscopic ultrasound. She was referred
to Jefferson, where she was treated by
Ernest (Gary) Rosato, MD, Director of the
General Surgery Division, and Associate
Professor Benny Weksler, MD, MBA, a
thoracic surgeon. She was diagnosed with
Stage 2A cancer of the esophagus, but the
team offered her an excellent treatment
plan. Prior to any surgery, Florence
underwent chemotherapy and radiation
therapy at the Tunnel Cancer Center in
Delaware to shrink the tumor as much as
possible. Then, at Jefferson, she underwent
a laparoscopic esophagectomy, which is
an innovative, minimally invasive surgery
with a relatively short recovery.
Jefferson is the only area hospital offering a
unique team approach which provides the
patient with the expertise of two surgeons
trained in minimally invasive surgery
(MIS). Dr. Weksler operates on the part of
the esophagus in the chest and Dr. Rosato
operates on the portion in the abdomen.
“My experience with Jefferson was none
other than outstanding,” says Florence.
“In addition to the kindness and respect
for me as an individual, it was a great
comfort to have such an experienced,
compassionate team with a successful track
record.” Florence’s stay in the hospital was
only 11 days, and she was pleased that she
was “back to normal” within just 10 days
of returning home.

Dr. Ernest (Gary) Rosato, Director of the General Surgery Division, and Florence Jackson are pleased
with her quick recovery and good prognosis following a minimally invasive esophagectomy to treat
Stage 2A esophageal cancer.

Jefferson is also the only hospital in the
Philadelphia region performing a high
volume of laparoscopic esophagectomies—
25 during 2008, and the Department
expects to double that number in 2009.
A study of those cases demonstrates a

Jefferson is also the only hospital
in the Philadelphia region
performing a high volume of
laparoscopic esophagectomies...
decrease in morbidity over open surgeries.
Dr. Rosato explains the benefits of this
procedure: “With conventional ‘open’
surgeries, the incisions are large and painful,
and the hospital stay is longer,” he says.
“Laparoscopic surgery results in shorter
recovery and patient hospitalization.”

Dr. Rosato also emphasizes Jefferson’s
commitment to the latest training and
technology. “We have steadily increased
our volume of minimal invasive surgeries
over the last four years,” he explains, “and
we are now training residents and a fellow
in the specialty.” Jooyeun Chung, MD,
the current Minimally Invasive Surgery
Fellow and a graduate of Jefferson’s
residency program, has already built
an impressive record with more than
30 minimally invasive surgeries for the
esophagus. “We are aggressively taking
the lead by developing one of the most
experienced MIS/GI/Thoracic capabilities
in Philadelphia,” says Dr. Rosato, “and
are setting the tone and pace for what will
become the future of general surgery.”
For more information about
Minimally Invasive Surgery visit:
www.jeffersonhospital.org/keyhole
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The Surgeon Speaks

Dr. Benny Weksler, who is Board
Certified in Surgery and Thoracic
Surgery, is a leader in the innovative
technique of robotic surgery. “Like
laparoscopic surgery, “Dr. Weksler
explains, “robotic surgery is done via
only a few small incisions. However,
instead of holding the surgical
instruments, the surgeon sits at a
control panel and utilizes robotic arms
to move the instruments.” He notes
that robotic surgery is far safer because
it offers greater precision, smaller
incisions, decreased blood loss, and less
pain for the patient.
The only robotic system approved by
the Food and Drug Administration is
the da Vinci® Surgical System, named
after the famous artist who invented the
first robot. “We are the only facility in
Philadelphia using robotic surgery for
thoracic operations,” says Dr. Weksler.
In 2008, Jefferson performed seven
operations utilizing this exciting new
technology. That number will increase
in 2009 and already includes four robotassisted esophagectomies for patients
like Florence Jackson.
Benny Weksler, MD, MBA
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